MarketPulse — Real-Time Financial News & Market Analysis

German Chancellor Merz visits China with 30 business executives to strengthen economic ties, boost trade, and expand AI collaboration between Berlin and Beijing.

German Chancellor Merz visited China with 30 executives, meeting Xi Jinping to strengthen bilateral trade ties worth $292 billion and deepen economic cooperation.

German Chancellor Merz visited China with 30 business executives, reaffirming EU-China trade ties. Germany-China bilateral trade reached $292 billion in 2025.

German Chancellor Merz visited China with 30 executives, reaffirming commitment to economic cooperation. The trip highlights Germany's strong trade ties with China despite geopolitical tensions.

German Chancellor Merz visits China with 30 executives, reaffirming economic ties. Bilateral trade hit $292 billion in 2025 as both nations emphasize multilateralism.

German Chancellor Merz visited China with 30 corporate executives, reinforcing Berlin-Beijing economic ties. China remains Germany's largest trading partner with $292 billion in annual trade.

German Chancellor Merz visits China with 30 corporate executives to strengthen economic ties. Bilateral trade reached $292 billion in 2025, with China as Germany's largest trading partner.

German Chancellor Merz visited China with business executives to deepen economic ties. Trade reached $292B in 2025, with tech partnerships like BMW's AI integration expanding cooperation.

German Chancellor Merz visited China with 30 business executives, reinforcing bilateral economic ties worth $292 billion annually and signaling expanded strategic cooperation between Berlin and Beijing.

German Chancellor Merz visits China with 30 corporate executives to strengthen bilateral trade and technology cooperation, as BMW plans to integrate Chinese AI into vehicles.

Prediction market assigns just 12% odds to Bitcoin hitting $150K by 2026, reflecting post-decline caution despite institutional optimism and historical recovery patterns.

Portnoy Law Firm sues Corcept Therapeutics over alleged misrepresentations about drug candidate relacorilant, following FDA rejection that caused stock to plummet 50%.

Avalon GloboCare raises $3.25M with potential $6.5M more through warrants. Funds will repay debt and support operations.

ADP stock down 35% from highs amid labor market concerns, but company maintains strong fundamentals, dividend growth, and trades below historical valuation multiples.

IonQ stock jumped 21% on Q4 results beating guidance by 55% and robust 2026 revenue outlook, though the company remains unprofitable.

Kratos Defense raises $1.17B through equity offering to fund growth initiatives, capital expenditures, and strategic acquisitions of Nomad and Orbit.

Duos Technologies raises $65M through stock offering to expand its Edge Data Center business segment amid strong 288% revenue growth.

RNWF had individual defendant dismissed in Washington litigation. Company refiling motion to address procedural issues before seeking FINRA approval for restructuring and ticker symbol change.

Mesoblast reports strong H1 results with Ryoncil® revenue of $51.3M and narrowed net losses. Commercial expansion underway with 49 transplant centers operational and FY2026 guidance of $110-120M revenue.

UniQure faces securities lawsuit alleging material misrepresentations about its Huntington's Disease trial design and FDA approval status. Lead plaintiff deadline is April 13, 2026.